Cystic Fibrosis
MoliChem launches phase II for evaluation of Moli1901 in CF participants
Published in Gene Therapy Weekly, July 11th, 2002
CF is a genetic disease characterized in the lung by abnormal chloride and water transport from the pulmonary lining cells into the lumen. This anomaly causes the chronic formation of tenacious mucus, leading to infection and a vicious cycle of inflammatory lung damage that debilitates and leads to early death.
Moli1901 may normalize the mucus composition in the lung by activating an alternative chloride and water channel that is present in the lung lining cells of CF patients.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-07-11)
More Articles from Gene Therapy Weekly
- Kidney Cancer
Antiangiogenic gene therapy using liver as conduit stifles renal carcinoma - Monoclonal Antibodies
Inducible gene expression extends survival of B-cell hybridomas - Breast Cancer
Strategy of eliminating Stat5a might reduce breast cancer cell survival - Immunogene Therapy
Transduced tumor cells are prime candidates for becoming tumor vaccines - Transduction
Gene transfer to cancers residing in muscles may present problem - Adjuvants
Cells expressing granulocyte macrophage-colony stimulating factor prevent gliosarcomas - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
